Hearing Loss Trial, Recruiting (NCT05805384)

Hearing Loss Trial, Recruiting NCT05805384 Sponsor: NYU Langone Health Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT05805384 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be at least 12 years old.
You must already have a cochlear implant and have had it for at least 6 months (any brand is acceptable).
Your hearing loss must have happened after you had already learned to speak and understand language (known as post-lingual deafness).
If the participant is a child, the trial doctor must feel they are mature enough to take part in the study activities.

Who may not be able to join:

You cannot join if you do not have a cochlear implant.
You cannot join if you are under 12 years old.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David M. Landsberger, NYU Langone Health

Phone: 212-263-8455

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05805384

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: 212-263-8455

More information: https://clinicaltrials.gov/study/NCT05805384

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be at least 12 years old.
You must already have a cochlear implant and have had it for at least 6 months (any brand is acceptable).
Your hearing loss must have happened after you had already learned to speak and understand language (known as post-lingual deafness).
If the participant is a child, the trial doctor must feel they are mature enough to take part in the study activities.

Who may not be able to join:

You cannot join if you do not have a cochlear implant.
You cannot join if you are under 12 years old.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

1 March 2023

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Percent of Words Correctly Recognized in Noisy Conditions with SEDA NR; Percent of Words Correctly Recognized in Noisy Conditions without NR; Percent of Words Correctly Recognized in Quiet Conditions with SEDA NR; Percent of Words Correctly Recognized in Quiet Conditions without NR; Visual Analogue Scale (VAS) Rating of SEDA NR; Percent of Words Correctly Recognized in Noisy Conditions with Clinical NR; Percent of Words Correctly Recognized in Quiet Conditions with Clinical NR; Percent of Words Correctly Recognized with no SEDA NR; Percent of Words Correctly Recognized with Standard SEDA NR; P...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov